HRTX
Heron Therapeutics·NASDAQ
--
--(--)
--
--(--)
6.72 / 10
Outperform
Analyst coverage is limited to one Strong Buy, yielding a bullish consensus despite a 50% historical win rate. Fund‑flow score is 7.95 (good), with overall, block and extra‑large inflows positive, while small, medium and large investors show negative trends.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-09
InstitutionHC Wainwright & Co.
Times predicted2
Historical Win Rate50.0%
Is money flowing into or out of HRTX?
- HRTX holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 6.72/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
